Unit, Electrosurgical, Endoscopic (with Or Without Accessories)
Gastroenterology, Urology · 21 CFR 876.4300
Recent MDR events
17,379 adverse event reports on file
- TRUEtome Jag 44Jul 31, 2026MalfunctionBoston Scientific Corporation3005099803-2026-03110
- RezumJul 31, 2026InjuryBoston Scientific Corporation2124215-2026-41203
- Autotome RX 39Jul 31, 2026MalfunctionBoston Scientific Corporation3005099803-2026-03116
- RezumJul 31, 2026InjuryBoston Scientific Corporation2124215-2026-41270
- TRUEtome 44Jul 31, 2026MalfunctionBoston Scientific Corporation3005099803-2026-03124
- Single Use 3-Lumen Sphincterotome VJul 30, 2026MalfunctionAomori Olympus Co., Ltd.9614641-2026-00791
- Single Use Electrosurgical KnifeJul 30, 2026MalfunctionAomori Olympus Co., Ltd.9614641-2026-00792
- RezumJul 30, 2026InjuryBoston Scientific Corporation2124215-2026-41022
- RezumJul 30, 2026InjuryBoston Scientific Corporation2124215-2026-41027
- RezumJul 30, 2026InjuryBoston Scientific Corporation2124215-2026-41028
Event type breakdown
Recalls
121 recall events for this product code
- Wilson-Cook Medical Inc.Open, ClassifiedFeb 13, 2026
Teslatome Bipolar Sphincterotomes
Due to product that may contain a void in the material that separates the wire guide and cutting wire lumens, which may cause an inappropriate path of current during cutting.
Z-1362-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1158-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
AXIOS Stent and Electrocautery-Enhanced Delivery System - 6mm x 8mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1159-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
AXIOS Stent and Electrocautery-Enhanced Delivery System - 8mm x 8mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1160-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 6mm x 8mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1161-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
*HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 8mm x 8mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1162-2026 · View FDA record ↗ - Boston Scientific CorporationOpen, ClassifiedFeb 5, 2026
*HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 20mm x 10mm;
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
Z-1163-2026 · View FDA record ↗ - Olympus Corporation of the AmericasOpen, ClassifiedFeb 5, 2026
Brand Name: CleverCut
Devices which did not undergo thermoforming could deform and lose performance.
Z-1268-2026 · View FDA record ↗ - Olympus Corporation of the AmericasOpen, ClassifiedFeb 5, 2026
Product Name: Single Use Sphincterotome V (Distal Wire guided)
Devices which did not undergo thermoforming could deform and lose performance.
Z-1269-2026 · View FDA record ↗ - Olympus Corporation of the AmericasOpen, ClassifiedFeb 5, 2026
Product Name: Disposable Triple Lumen Sphincterotome
Devices which did not undergo thermoforming could deform and lose performance.
Z-1270-2026 · View FDA record ↗
Registered firms
329 firms currently registered for this product code
Guenter Bissinger Medizintechnik Gmbh
TENINGEN Baden-Wurttemberg, DE
Rz Medizintechnik Gmbh
TUTTLINGEN Baden-Wurttemberg, DE
Grace Manufacturing Inc
Russellville, AR, US
Boston Scientific Corporation
Marlborough, MA, US
Cme Devices Ltd
CHEPSTOW Monmouthshire, GB
Aomori Olympus Co., Ltd. Hirosaki Site
Hirosaki-shi Aomori, JP
Boston Scientific Corporation
SPENCER, IN, US
Boston Scientific Corporation
El Coyol Alajuela, CR
Boston Scientific Corporation
Coventry, RI, US
Freudenberg Medical, Llc
Jeffersonville, IN, US
Sei Medical S.a. De C.v.
Juarez Chihuahua, MX
Creo Medical Ltd
CHEPSTOW Monmouthshire, GB
Aomori Olympus Co., Ltd. Kuroishi Site
KUROISHI-SHI Aomori, JP
Aesculap, Inc.
CENTER VALLEY, PA, US
Olympus Medical Systems Corp.
HACHIOJI-SHI Tokyo, JP
Boston Scientific Limited
GALWAY, IE
Gyrus Acmi, Inc.
Brooklyn Park, MN, US
Ovesco Endoscopy Usa
Cary, NC, US
Merit Medical Uk Limited
Earley Reading, GB
510(k) clearances
188 clearances for this product code
- Taewoong Medical Co., Ltd.May 21, 2026
K260962 · Sphincterotome
- Francis Medical, Inc.Nov 26, 2025
K252388 · Vanquish Water Vapor Ablation Device
- Olympus Medical Systems CorporationNov 25, 2025
K252889 · Single Use 3-Lumen Needle Knife V (KD-V441M, KD-V451M)
- Olympus Medical Systems Corp.Oct 17, 2025
K250945 · Single Use Preloaded Sphincterotome V (Distal Wire Guided) (KD-VC600 Series); Single Use Sphincterotome V (Distal Wire Guided) (KD-VC400 Series); Single Use 3-Lumen Sphincterotome (KD-V Series); Disposable Triple Lumen Sphincterotome (KD Series)
- Olympus Medical Systems CorporationOct 10, 2025
K250351 · Single Use Electrosurgical Knife (KD-612L, KD-612U); Single Use Electrosurgical Knife (KD-620UR); Single Use Electrosurgical Knife (KD-650L, KD-650U)
- Wilson-Cook MedicalSep 29, 2025
K251104 · SureTome SW Sphincterotome with DomeTip
- Aqua Medical, Inc.Aug 8, 2025
K251226 · Aqua Medical RF Vapor Ablation System
- Boston Scientific CorporationJun 11, 2025
K250584 · Rezum System